APA (7th ed.) Citation

RN, S., A, J., S, W., C, S., A, J., A, K., . . . G, P. (2026). Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01492-0

Chicago Style (17th ed.) Citation

RN, Swain, et al. "Fixed-duration Cytarabine Consolidation Improves Relapse-free Survival over Indefinite AZA-VEN in Younger AML." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01492-0.

MLA (9th ed.) Citation

RN, Swain, et al. "Fixed-duration Cytarabine Consolidation Improves Relapse-free Survival over Indefinite AZA-VEN in Younger AML." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01492-0.